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Genotypic and Clinical Spectrum of Self-Improving
Collodion Ichthyosis: ALOX12B, ALOXE3, and
TGM1 Mutations in Scandinavian Patients
Anders Vahlquist1, Anette Bygum2, Agneta Ga˚nemo1, Marie Virtanen1, Maritta Hellstro¨m-Pigg3,
Gitte Strauss4, Flemming Brandrup2 and Judith Fischer5
Infants born with autosomal recessive congenital ichthyosis (ARCI) are often encapsulated in a collodion
membrane, which shows a lamellar or erythrodermic type of ichthyosis upon shedding. However, some babies
show a nearly normal underlying skin after several weeks, a phenotype called ‘‘self-healing collodion baby’’
(SHCB). Mutations in two genes, TGM1 and ALOX12B, have previously been implicated in the etiology of SHCB,
but the full genotypic spectrum remains to be determined. DNA sequencing in 11 Swedish and 4 Danish SHCB
patients showed ALOX12B mutations in eight cases, ALOXE3 mutations in three cases, and TGM1 mutations in
one case. In three patients, we could not find mutations in any of the known ARCI genes. In all cases, a
spontaneous shedding of the collodion membrane occurred 2–4 weeks after birth. When re-examined at 2–37
years of age, the patients showed skin xerosis, a mild or focal scaling, palmar hyperlinearity with keratoderma,
and a frequent appearance of red cheeks and anhidrosis. Thus, we propose replacing SHCB with the term
‘‘self-improving collodion ichthyosis’’ (SICI). In conclusion, ALOX12B mutations are the leading cause of SICI
in Scandinavia, followed by ALOXE3 mutations, which have not been previously associated with this variant
of ARCI.
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INTRODUCTION
Infants born with a glue-like hyperkeratotic membrane
covering the entire body are called ‘‘collodion babies.’’
They frequently also show everted eye lids (ectropion) and
lips (eclabium). The collodion membrane is associated
with an impaired skin barrier function, with increased
transepidermal water loss. Potential complications are
hypothermia, dehydration, and hypernatremia, usually re-
quiring observation and treatment in an intensive neonatal
care unit. The collodion membrane is usually shed within 1–3
weeks, showing an underlying lamellar ichthyosis (LI)
or congenital ichthyosiform erythroderma (CIE), the most
common phenotypes of autosomal recessive congenital
ichthyosis (ARCI). However, in about 10–25% of all cases,
the membrane is shed without showing residual signs of
ichthyosis—a condition known as ‘‘self-healing collodion
baby’’ (SHCB) (Dean, 1921; Frenk and de Techtermann,
1992; Van Gysel et al., 2002). For reasons given in this paper,
we propose to complement SHCB by the more adapted term
‘‘self-improving collodion ichthyosis’’ (SICI), also suitable for
older children and adult patients who show some remaining
skin symptoms.
Over the last decade at least six different genes have been
implicated in the etiology of ARCI, all of which encode
proteins essential for the formation of the skin barrier (Huber
et al., 1995; Russell et al., 1995; Jobard et al., 2002; Lefevre
et al., 2003, 2004, 2006; Fischer, 2009). The most common
cause of LI/CIE is inactivating mutations in the TGM1 gene,
which encodes transglutaminase-1, an enzyme that cross-
links proteins in the cornified cell envelope (Russell et al.,
1995; Farasat et al., 2009). Two unusual point mutations in
TGM1, which reduced the enzyme activity in utero but not
in vivo, were the first causes of SHCB/SICI to be reported
(Raghunath et al., 2003).
Additional ARCI-associated genes encode enzymes or
transport proteins in the lipoxygenase pathway, which
produces metabolites required for a proper deposition of
lipids between the horny cells (Jobard et al., 2002; Brash
et al., 2007; Epp et al., 2007). For example, ALOX12B and
ALOXE3 gene mutations have been associated with a mild
type of ichthyosis, which does not always fit into the tradi-
tional LI/CIE classification (Jobard et al., 2002). This
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phenotype is sometimes described as congenital ichthyosis
with fine or focal scaling (Ganemo et al., 2003; Eckl et al.,
2009). Recently, Harting et al. (2008) described two
American cases of SHCB/SICI with previously unreported
mutations in the ALOX12B gene; the collodion phenotype in
these cases later changed into a mild ichthyosis.
In this study, we successfully determined the genotype–-
phenotype relationship in 12 of 15 SICI patients identified by
nationwide screenings for ARCI in Sweden and Denmark,
including over 250 ichthyosis patients. Besides several types
of ALOX12B and TGM1mutations, we report for the first time
ALOXE3 mutations as a cause of SICI, and further elaborate
the spectrum of persisting skin symptoms in this group of
patients.
RESULTS
Of the 15 SICI patients (9 females and 6 males), 12 showed
homozygous or compound heterozygous mutations in at least
one of the ARCI genes investigated (Table 1). Eight of the
patients had ALOX12B mutations, three had ALOXE3
mutations, and one patient had TGM1 mutations. There
was no consanguinity reported. Prematurity (3–5 weeks) was
noted in four cases. At birth, all babies were covered by a
variably thick collodion membrane and ectropion was
present in eight cases (Table 1). The membrane was
spontaneously shed after 2–4 weeks, exposing an almost
normal-looking skin, which however later developed signs of
mild ichthyosis (Figure 1a–d). When re-examined at 2–37
years of age, all patients showed varying degrees of dry skin
with fine or focal scaling (Table 1). Typical features were
scaling in the armpits (Figure 1e), acral hyperkeratosis and
keratoderma (Figure 1f), coarse scales on the scalp (Figure
1g), and a fine scaling around the neck (Figure 1h), together
with xerotic extremities and red cheeks that were stinging
when exposed to sea water or certain emollients (Figure 1i).
All patients, except the one with TGM1 mutations, had
moderate-to-severe anhidrosis, which was manifested as
fatigue and intense skin erythema during exercise and in a
hot environment. Some patients occasionally noted sweating
on a small patch in the face. Besides these symptoms, the
patients were healthy except for minor psychomotor pro-
blems and a sunlight sensitive skin in two cases each.
Five patients carried the same ALOX12B mutation, which
replaces an A to a G in position 1,562, leading to a
replacement of tyrosine with cysteine at aa position 521
(p.Tyr521Cys). Four of them (patients P3, P4, P6, and P7)
were homozygous for this mutation, and one patient (P2) was
a compound heterozygote for this mutation, and a second
missense mutation (c.199A4T; p.Ile67Phe). Another patient
(P1) was homozygous for a missense mutation in exon 11
(c.1385G4A; p.Gly462Asp), and one further patient (P5) was
a compound heterozygote for p.[Val527Met]þ [Ala597Glu]
in exon 12 and 14 respectively. Finally, one Danish patient
(P8) was homozygous for a known splice site mutation at
position 1654þ 3A4G of exon 12 (Table 1).
Three SICI patients presented mutations in ALOXE3; one
Swedish patient (P10) was homozygous for a T-to-C mutation
at position 1,280 in exon 9 (p.Leu427Pro). Two other patients
(P9 and P11) were compound heterozygotes; they shared the
same missense mutation at nucleotide position 1,889
(p.Pro630Leu), and they had a different second mutation
(p.Cys109X and p.Arg234X).
The last patient (P12) showed compound heterozy-
gous mutations in exon 6 of TGM1: one splice site mutation
c.877-2A4G and one already known missense mutation
c.919C4G, which corresponds to p.Arg307Gly on the pro-
tein level. These mutations probably result in a similar effect
on the transglutaminase enzyme activity as previously repor-
ted in a German SICI patient (Raghunath et al., 2003). Her
persistent skin symptoms were mild (see Figure 1h) and she
had a normal sweating ability.
DISCUSSION
To the best of our knowledge, this is the largest study of SICI
etiology reported to date. It confirms that ALOX12B gene
mutations are a common cause of this mostly transitory form
of ARCI (Harting et al., 2008), accounting for 67% of 12
genotyped cases in Scandinavia. Many of these patients were
either homozygous for the p.Tyr521Cys mutation or carried at
least one such mutation. Speculatively, this type of missense
mutation in ALOX12B could result in a protein misfolding
that negatively affects the enzyme activity only under in utero
conditions, thus explaining a dramatic improvement of epi-
dermal cornification after birth. Three out of the six ALOX12B
mutations have been described previously: p.Tyr521Cys (Eckl
et al., 2005; Eckl et al., 2009), pVal527Met (Lesueur et al.,
2007), and c.[1654þ3A4G] (Eckl et al., 2009). Interest-
ingly, none of these former patients have been described with
a SHCB phenotype, suggesting that other factors may have a
role in the developing of this phenotype. However, all seven
of the previously described patients show a mild phenotype
including fine scaling and mild erythema. The same
phenomenon has also been observed in patients with specific
TGM1 mutations, which leads to SICI in the majority of cases,
but in some cases to the more common LI.
The second most common cause of SICI in our study was
ALOXE3 mutations. This gene has been previously associated
with ARCI (Jobard et al., 2002), but has never been reported
as a cause of SHCB/SICI. Two of the three mutations have
been previously described in adult patients without the SICI
phenotype: p.Arg234X (Jobard et al., 2002) and p.Pro630Leu
(Eckl et al., 2005). As ALOXE3 and ALOX12B encode
enzymes operating in the same metabolic pathway (Jobard
et al., 2002; Brash et al., 2007; Epp et al., 2007) and
mutations in both genes are relatively common as causes of
ARCI (Eckl et al., 2009; Fischer, 2009), our finding of
ALOXE3 mutations in 25% of Scandinavian SICI patients may
not be so surprising.
Only one of our SICI patients had compound heterozygous
TGM1 mutations, confirming a similar rare finding in a
German patient (Raghunath et al., 2003). The first mutation
p.Arg307Gly has been described in patients with SICI,
whereas mutations of the same arginine codon 307 replaced
by a tryptophan codon (p.Arg307Trp) are known to be asso-
ciated with traditional LI (Farasat et al., 2009). In addition, the
second mutation (c.877-2A4C), which is a splice site
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mutation, has already been described (Farasat et al., 2009).
However, TGM1 mutations of other types are found in nearly
50% of Scandinavian collodion babies who eventually
develop LI or CIE (Ganemo et al., 2003; Pigg et al.,
unpublished). Clearly, TGM1 mutations underlying SICI
are extremely rare events compared with ALOXE3 and
Table 1. Clinical and genotypic features of 12 patients who were born as collodion babies but later showed
only minimal signs of ichthyosis
Patient
no.,
origin Age1 Sex
Ectropion
at birth
Current type
of ichthyosis
Palmoplantar
keratoderma Anhidrosis
Special clinical
features
Gene,
mutation Effect Exon
ALOX12B
P1
SV
12 M ? Fine scaling with
focal accentuation
Moderate + Light sensitivity, minor
deafness, and slight
mental retardation
c.[1385G4A]
+[=]
p.[Gly462Asp]
+[=]
11
P2
SV
14 F + Fine scaling,
acral keratosis
Mild + ADHD c.[199A4T]
+[1562A4G]
p.[Ile67Phe]
+[Tyr521Cys]
2
12
P3
SV
14 M + Xerosis Mild + Red cheeks, stinging in
contact with sea water
c.[1562A4G]
+[=]
p.[Tyr521Cys]
+[=]
12
P4
SV
9 M + Fine scaling,
slight erythema
Mild + Red cheeks, prematurity2,
and mild autism
c.[1562A4G]
+[=]
p.[Tyr521Cys]
+[=]
12
P5
SV
4 F + Scaling around
armpits
Moderate + Stiff fingers, scalp
hyperkeratosis, red cheeks,
and prematurity2
c.[1579G4A]
+[1790C4A]
p.[Val527Met]
+ [Ala597Glu]
12
14
P6
SV
2 F + Scaling around
armpits, xerosis
Mild + Red cheeks, stinging in
contact with sea water,
and pruritus
c.[1562A4G]
+[=]
p.[Tyr521Cys]
+[=]
12
P7
DK
12 F + Fine scaling,
scalp keratosis
Palmar
hyperlinearity
+ Acral lichenification, red
cheeks, and prematurity2
c.[1562A4G]
+[=]
p.[Tyr521Cys]
+[=]
12
P8
DK
37 F ? Fine scaling,
scalp keratosis
Palmar
hyperlinearity
+ Light sensitivity c.[1654+3A4G]
+[=]
splice site
+[=]
12
ALOXE3
P9
DK
6 F + Fine scaling,
scalp keratosis
Palmar
hyperlinearity
Heat
intolerance
Allergic rhinitis and
prematurity2
c.[327C4A]
+[1889C4T]
p.[Cys109X]
+[Pro630Leu]
2
14
P10
SV
7 F  Fine scaling — + Pruritus c.[1280T4C]
+[=]
p.[Leu427Pro]
+[=]
9
P11
SV
22 M  Fine scaling — + Syndactyly of
two fingers
c.[700C4T]
+[1889C4T]
p.[Arg234X]
+[Pro630Leu]
6
14
TGM1
P12
SV
18 F + Fine scaling,
xerosis
Fissures  Much better in
summer
c.[877-2A4G]
+[919C4G]
Splice site
p.[Arg307Gly]
6
6
ADHD, attention-deficit hyperactivity disorder; DK, Danish origin; F, female; M, male; SV, Swedish origin.
1Age in years at last examination.
2Prematurity of 3-5 weeks.
The symbol ‘‘+[=]’’ indicates homozygous mutations, according to the Human Genome Variation Society nomenclature.
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ALOX12B mutations, which seem to be the leading cause
of SICI.
Five of the mutations identified in this study have not
yet been described in the literature; they include one
nonsense mutation (c.Cys109X) and three missense mutations
(p.Ile67Phe, p.Gly462Asp, and p.Ala597Glu) in ALOX12B,
and one missense mutation in ALOXE3 (p.Leu427Pro). None
of the mutations in our 12 patients were found in 280
chromosomes from a Caucasian control population.
ICHTHYIN mutations are another relatively common
cause of ARCI in Scandinavia (Dahlqvist et al., 2007),
but this genotype is seldom associated with a collodion
membrane at birth (A. Vahlquist et al., unpublished obser-
vation); none of our SICI patients had this genotype.
Figure 1. Examples of phenotypic variants of self-improving collodion ichthyosis. Patient P5 with ALOX12B mutations (a) at birth showing collodion membrane
and ectropion, (b) at the age of 2 months showing normal-appearing skin, and (c and d) at the age of 6 years showing acral hyperkeratosis and xerosis.
Other examples of skin symptoms in patient P6 with ALOX12B mutations at the age of 2–18 months (e and f), in patient P10 (at age 7 months) with ALOXE3
mutations (g), in the neck of patient P12 (at age 18) with TGM1 mutations (h), and in patient P2 (at age 14) with ALOX12B mutations (i). For further details,
see Table 1. Patients’ parents gave permission for the use of identifiable photographs.
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However, one of the patients in this study (P9), who was
a compound heterozygote for ALOXE3 mutations, also
carried one heterozygous ICHTHYIN mutation. Whether this
mutation acts as a disease modifier in SICI is presently
unknown.
Of the 15 SICI patients, 3 did not show any mutations in
the investigated ARCI genes (ALOXE3, ALOX12B, ABCA12,
CGI-58, CYP4F22, ICHTHYIN, and TGM1). We therefore
conclude that mutations in other genes that remain to be
identified may also lead to a SICI phenotype.
Our study suggests that the prevalence of SICI in Sweden
and Denmark is around 1 per million (15 cases in a
population of 14 million). However, this is probably a low
estimate, because many SICI patients will never be correctly
diagnosed because of the transient nature of the skin
problems. For example, an elderly ARCI patient with no
detailed knowledge about the events surrounding his/her
birth is unlikely ever to be diagnosed as having SICI. Even
today, when a SICI baby is born in a smaller hospital and
there is no dermatological expertise available, a thin
collodion membrane may be misinterpreted as post-term
skin dryness or debris of vernix caseosa remaining on the
skin. In addition, male infants with X-linked recessive
ichthyosis sometimes show a thin collodion-like membrane
at birth that may confuse diagnosis (Hoyer et al., 1986;
Hernandez-Martin et al., 1999; A. Vahlquist, unpublished
observation).
In fact, the term ‘‘SHCB’’ may itself be confounding.
Although when seeing a collodion baby in the neonatal
period the term is quite useful to distinguish one ARCI
subtype with good prognosis from another subtype with
worse prognosis, the word ‘‘self-healing’’ spuriously implies
that the skin of the patient will always look normal after the
collodion has been shed. On the contrary, when our SICI
patients were re-examined at 2–37 years of age, all showed
mild signs of ichthyosis, such as xerosis and a fine scaling
especially in the axillae and around the neck, as well as red
cheeks and a varying degree of anhidrosis associated with
heat intolerance. Similarly, Harting et al. (2008) noted
persistent skin symptoms in the two SICI cases they
described. A further drawback of the previous term ‘‘SHCB’’
is that it implies that only babies are affected by this subtype
of ARCI, making it unsuitable as a diagnosis when the patient
is older. Instead, we propose ‘‘SICI’’ as a better or comple-
mentary name for this pleiomorphic form of ichthyosis.
In conclusion, SICI illustrates the genetic diversity and
clinical overlap between different types of ARCI. Only a
careful dissection of clinical and genetic findings can define
the SICI subtype of ARCI. It is important for clinicians to be
aware of cases of congenital ichthyosis, in which a spon-
taneous transition from a severe to a mild phenotype occurs
and to understand the recessive nature of this disease when
asked for genetic counseling.
MATERIALS AND METHODS
The patients were recruited by a national survey of ARCI that
has been ongoing in Sweden since 1997 (Vahlquist et al., 2003) and
in Denmark since 2004 (A. Bygum et al., unpublished observation).
The study has been approved by the regional ethics commit-
tees (EPN) in Uppsala and Odense, and carried out in accordance
with the Declaration of Helsinki Principles. Briefly, the survey
involved a team of doctors and nurses examining the patients in a
standardized manner and collecting data from other hospital
departments where the patients had received previous medical care
for ichthyosis. After informed consent, EDTA blood sample was
collected from the patient and the parents if available. Among nearly
260 ARCI patients, 15 cases of SICI were identified. Some of these
patients were examined by us soon after birth and followed up
prospectively for several years. Other patients (children and adults)
with typical features of SICI at birth were identified retrospectively
by interviewing the patient or parents about the neonatal period, by
looking at photos taken soon after delivery, and by consulting the
patients’ hospital records. The age at the last examination is
indicated in Table 1, together with other characteristics of the
patients.
Blood DNA was initially screened for TGM1 and ICHTHYIN
mutations at the Department of Clinical Genetics (Uppsala
University), using the same approaches as previously described
(Pigg et al., 1998; Dahlqvist et al., 2007). The STS gene was
investigated in boys to exclude X-linked recessive ichthyosis with
neonatal onset. Samples without TGM1 or ICHTHYIN mutations
were sent to Evry (JF, CNG) for further sequencing of the ALOX genes
and other ARCI-related genes (Jobard et al., 2002; Lefevre et al.,
2003, 2006; Lesueur et al., 2007; Fischer, 2009).
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